Basta Steven L (CIK 1417397) reported 9 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-12). Recent activity: Buy PHAT (12,362 shares), Sell PHAT (6,277 shares), Buy PHAT (251,034 shares), Buy PHAT (62,038 shares), Sell PHAT (31,502 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-12 | Phathom Pharmaceuticals, Inc. (PHAT) | President and CEO | Buy | 12,362 | $0 |
| 2026-02-12 | Phathom Pharmaceuticals, Inc. (PHAT) | President and CEO | Sell | 6,277 | $80,471 |
| 2026-01-02 | Phathom Pharmaceuticals, Inc. (PHAT) | President and CEO | Buy | 251,034 | $0 |
| 2025-12-19 | Phathom Pharmaceuticals, Inc. (PHAT) | President and CEO | Buy | 62,038 | $0 |
| 2025-12-19 | Phathom Pharmaceuticals, Inc. (PHAT) | President and CEO | Sell | 31,502 | $483,871 |
| 2025-12-02 | Phathom Pharmaceuticals, Inc. (PHAT) | President and CEO | Buy | 90,000 | $0 |
| 2025-12-02 | Phathom Pharmaceuticals, Inc. (PHAT) | President and CEO | Sell | 48,375 | $755,618 |
| 2025-09-26 | Phathom Pharmaceuticals, Inc. (PHAT) | President and CEO | Buy | 90,000 | $0 |
| 2025-09-26 | Phathom Pharmaceuticals, Inc. (PHAT) | President and CEO | Sell | 48,375 | $564,052 |
Source: SEC Form 4 filings · as of 2026-02-12